122 related articles for article (PubMed ID: 36153645)
1. RAB3D, upregulated by aryl hydrocarbon receptor (AhR), promotes the progression of prostate cancer by activating the PI3K/AKT signaling pathway.
Yu J; Qi H; Wang Z; Zhang Z; Song E; Song W; An R
Cell Biol Int; 2022 Dec; 46(12):2246-2256. PubMed ID: 36153645
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.
Zhang J; Kong R; Sun L
Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125a-5p modulates the proliferation and apoptosis of TM4 Sertoli cells by targeting RAB3D and regulating the PI3K/AKT signaling pathway.
Teng F; Hu F; Zhang M
Mol Hum Reprod; 2021 Sep; 27(9):. PubMed ID: 34273154
[TBL] [Abstract][Full Text] [Related]
4. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway.
Yi X; Zhang C; Liu B; Gao G; Tang Y; Lu Y; Pan Z; Wang G; Feng W
J Cell Mol Med; 2023 Feb; 27(3):403-411. PubMed ID: 36625246
[TBL] [Abstract][Full Text] [Related]
6. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
Ma X; Ren H; Zhang Y; Wang B; Ma H
Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
[TBL] [Abstract][Full Text] [Related]
7. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
10. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
11. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer.
Luo Y; Ye GY; Qin SL; Mu YF; Zhang L; Qi Y; Qiu YE; Yu MH; Zhong M
Int J Biochem Cell Biol; 2016 Jun; 75():53-62. PubMed ID: 27046094
[TBL] [Abstract][Full Text] [Related]
12. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
Hou Y; Li H; Huo W
Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868
[TBL] [Abstract][Full Text] [Related]
13. High expression of small GTPase Rab3D promotes cancer progression and metastasis.
Yang J; Liu W; Lu X; Fu Y; Li L; Luo Y
Oncotarget; 2015 May; 6(13):11125-38. PubMed ID: 25823663
[TBL] [Abstract][Full Text] [Related]
14. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway.
Xu S; Zhou W; Ge J; Zhang Z
Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471
[TBL] [Abstract][Full Text] [Related]
16. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways.
Gu Z; You Z; Yang Y; Ding R; Wang M; Pu J; Chen J
Bioengineered; 2021 Dec; 12(1):4719-4735. PubMed ID: 34338146
[TBL] [Abstract][Full Text] [Related]
19. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
[TBL] [Abstract][Full Text] [Related]
20. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
